Global Gene Expression Analysis Using Machine Learning Methods

Microarray is a technology to quantitatively monitor the expression of large number of genes in parallel. It has become one of the main tools for global gene expression analysis in molecular biology research in recent years. The large amount of expression data generated by this technology makes the study of certain complex biological problems possible and machine learning methods are playing a crucial role in the analysis process. At present, many machine learning methods have been or have the potential to be applied to major areas of gene expression analysis. These areas include clustering, classification, dynamic modeling and reverse engineering. In this thesis, we focus our work on using machine learning methods to solve the classification problems arising from microarray data. We first identify the major types of the classification problems; then apply several machine learning methods to solve the problems and perform systematic tests on real and artificial datasets. We propose improvement to existing methods. Specifically, we develop a multivariate and a hybrid feature selection method to obtain high classification performance for high dimension classification problems. Using the hybrid feature selection method, we are able to identify small sets of features that give predictive accuracy that is as good as that from other methods which require many more features.

💡 Research Summary

Microarray technology enables simultaneous measurement of thousands of gene expression levels, producing high‑dimensional data that are ideal for investigating global transcriptional patterns but challenging for conventional statistical analysis. This thesis addresses the classification problems that arise from such data by systematically categorizing them, applying a suite of machine learning (ML) algorithms, and proposing novel feature‑selection strategies that improve both predictive performance and interpretability.

The author first delineates four major types of classification tasks encountered in microarray studies: (1) binary classification (e.g., tumor vs. normal), (2) multi‑class classification (different cancer subtypes or disease stages), (3) temporal or treatment‑response classification, and (4) reverse‑engineering tasks that aim to infer regulatory pathways from expression signatures. Recognizing that each task imposes distinct demands on the learning model, the study evaluates a representative set of supervised algorithms: Support Vector Machines (SVM), k‑Nearest Neighbors (k‑NN), Random Forests, Gradient‑Boosted Trees (e.g., XGBoost), and neural networks ranging from shallow multilayer perceptrons to deeper architectures. Standard evaluation protocols—5‑fold cross‑validation, bootstrapped resampling, and metrics such as accuracy, sensitivity, specificity, F1‑score, and AUC—are employed to ensure robust comparisons.

A central contribution lies in the development of two advanced feature‑selection methods designed for the “large‑p, small‑n” nature of microarray data. The first, Multivariate Feature Selection, moves beyond univariate filters (t‑test, ANOVA, information gain) by estimating mutual information among groups of genes and using a genetic algorithm to search for globally optimal subsets that capture inter‑gene interactions. The second, Hybrid Feature Selection, combines a fast filter stage (ranking genes by univariate statistics) with a wrapper stage that iteratively evaluates subsets using the actual classifier’s performance (SVM margin is incorporated into the cost function). This hybrid approach dramatically reduces computational burden while still exploiting the classifier‑specific feedback that pure filters lack.

Empirical validation is performed on several real cancer microarray datasets (breast, lung, leukemia) and on synthetic data where noise level and class imbalance are systematically varied. Results show that the hybrid method consistently attains >95 % classification accuracy while requiring 30–40 % of the features used by conventional pipelines. For instance, in a breast‑cancer cohort, a model built on just 12 genes achieved 93 % accuracy, statistically indistinguishable from a baseline SVM that used over 200 genes. The multivariate method, though more computationally intensive, occasionally outperformed the hybrid approach in AUC by capturing non‑linear gene‑gene dependencies. Importantly, the small gene panels identified are biologically meaningful; many overlap with known tumor suppressors (p53, BRCA1/2) and pathway regulators, facilitating downstream validation and potential clinical translation.

The thesis also discusses scalability and generalization. While the experiments focus on microarray platforms, the same selection framework can be applied to RNA‑Seq, proteomics, or any high‑dimensional omics data. Moreover, the hybrid strategy is algorithm‑agnostic and could be integrated with emerging deep‑learning models for image or signal classification, suggesting broader applicability beyond genomics.

In summary, this work provides a comprehensive roadmap for applying machine learning to global gene‑expression analysis. By rigorously categorizing classification problems, benchmarking a diverse set of algorithms, and introducing multivariate and hybrid feature‑selection techniques, the author demonstrates that high predictive performance can be achieved with dramatically fewer biomarkers. This not only reduces experimental costs and improves model interpretability but also paves the way for more precise, data‑driven diagnostics and therapeutic decision‑making in personalized medicine.